Tag: portfolio

Bridging the Gap Between Making Money and Actually Building Wealth

LITTLE ROCK, Ark., June 25, 2026 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that it will report its second quarter 2026 financial results prior to the opening of trading on the Nasdaq Stock Exchange on July 30, 2026. A conference call to discuss those earnings will be held the same day at 8:30 AM Eastern Time.

JACKSONVILLE, Fla., June 25, 2026 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency Centers” or the “Company”) (NASDAQ: REG) will announce its second quarter 2026 earnings results on Wednesday, July 29, 2026, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings conference call on Thursday, July 30, 2026, at 11:00 a.m. ET.

LEXINGTON, Mass. and AMSTERDAM, June 25, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the closing of its previously announced underwritten public offering of 5,686,813 ordinary shares at a public offering price of $45.50 per share, which includes 741,758 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the offering. The aggregate gross proceeds to uniQure from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by uniQure, were approximately $259 million. All securities in the offering were sold by uniQure.

RESTON, Va., June 25, 2026 (GLOBE NEWSWIRE) -- Carahsoft Technology Corp., The Trusted Government IT Solutions Provider^®, today announced its human capital technology highlights and initiatives, as well as its upcoming events portfolio for this year, reaffirming its commitment to delivering innovative solutions to the Public Sector.

 ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production

VILNIUS, Lithuania, June 25, 2026 (GLOBE NEWSWIRE) -- WhiteBIT, the largest European exchange by traffic, has launched Crypto Bundles, a new investment product that allows users to gain exposure to portfolios of digital assets built around specific market themes and investment strategies.